Congruence Therapeutics Appoints Frank Taffy as Chief Business Officer [Yahoo! Finance]
Fortress Biotech, Inc. (FBIO)
Last fortress biotech, inc. earnings: 11/12 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
fortressbiotech.com
Company Research
Source: Yahoo! Finance
MONTREAL April 23, 2024 /PRNewswire/ -- Congruence Therapeutics, a leading computationally-driven biotechnology company developing a pipeline of novel small molecules for diseases with significant unmet medical need, announced today the appointment of Frank Taffy, JD as Chief Business Officer. Mr. Taffy joins Congruence with over two decades of experience in the biotechnology industry as an executive, board member, strategic advisor, and entrepreneur. Mr. Taffy most recently served as Senior Vice President, Head of Business Development, and Board Representative at Schrödinger, Inc. where he led the entire spectrum of business development activities and consummated multiple collaboration agreements with large pharmaceutical and biotechnology companies. In his new role, Mr. Taffy will lead the Company's corporate and business development and strategy functions, and along with other members of the executive team, assume responsibility for the next phase of growth of the Company as Con
Show less
Read more
Impact Snapshot
Event Time:
FBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FBIO alerts
High impacting Fortress Biotech, Inc. news events
Weekly update
A roundup of the hottest topics
FBIO
News
- Fortress Biotech, Inc. (NASDAQ: FBIO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- Fortress Biotech, Inc. (NASDAQ: FBIO) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
- Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]Yahoo! Finance
- Fortress Biotech Reports 2023 Financial Results and Recent Corporate HighlightsGlobeNewswire
- Mustang Bio stock climbs 9% amid drug development update [Seeking Alpha]Seeking Alpha
FBIO
Earnings
- 11/14/23 - Beat
FBIO
Sec Filings
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- 4/5/24 - Form 424B3
- FBIO's page on the SEC website